Review on Pharmaceutical Quality by Design (QbD)
DOI:
https://doi.org/10.22270/ajprd.v7i2.460Keywords:
Quality-by-design, design space, risk management, ICH guidelines.Abstract
Pharmaceutical Quality by Design (QBD) is a systematic approach to development that begins with predetermined objectives and emphasizes the understanding of production and processes and process control, based on sound science and quality risk management. Quality purchasing design (QBD) is emerging to increase the promise of providing safe and effective medicines to customers and promises to improve the efficiency of product quality. Quality means eligibility for use. The quality of the medication means that the product provides therapeutic benefits to the label reproducible and free from contamination on the label. In vivo or in vitro performance test can be evaluated for drug production. Dinette by Quality guarantees the performance of the product in vitro and the performance of the in vitro product in the in vivo product. So the quality design is related to the product.
Downloads
References
2. Chemistry/manufacturing/controls (CMC)”.Pharmatec Associates.
3. Early, John (2013); "Quality by Design, available at: https://www.qualitydigest.com/inside/quality-insider-article/quality-design-part-2.html..
4. Joseph A. Defeo & Juran, J. M. (2010); Juran's Quality Handbook: The Complete Guide to Performance Excellence 6/e; McGraw-Hill Education; 6 edition; 1136.
5. Chemolab Lebrun, Development of a new predictive modeling technique to find with confidence equivalence zone and design space of chromatographic analytical methods; Chemometrics and Intelligent Laboratory Systems; 2008; 91(1): 4-16.
6. Juran JM, Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services Free Press Business & Economics,1992; 538.
7. Lawrence XYu, Pharmaceutical quality by design: product and process development, understanding, and control; Pharm Res,2008; 25(4):781–791
8. General Principles and Practices" (PDF). FDA Guidance. Available at: https://www.fda.gov/downloads/drugs/guidances/ucm070336.pdf
9. Juran, JM, Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services Free Press Business & Economics; 538.
10. Rathore AS, Roadmap for implementation of quality by design (QbD) for biotechnology products; Trends Bio technol, 1992; 27(9):546-53.
11. Department of Health and Human Services U.S. Food and Drug Administration (2007); Pharmaceutical Quality for the 21st Century: https://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm128080.htm.
12. Early, John (2013),"Quality by Design, available at: http://www.qualitydigest.com/inside/quality-insider-article/quality-design-part-1.html.
13. International Conference on Harmonisation (ICH) Guidelines". at:https://research.rowan.edu/officeofresearch/compliance/irb/policiesguidance/ichguidelines/index.html.
14. ICH Quality Guidelines; available at: https://www.ich.org/products/guidelines/quality/article/quality-guidelines.html.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.